Jean-Jacques Body - Concepedia

Author

Jean-Jacques Body

Université Libre de Bruxelles

Also Known As

Jean-Jacques Body

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Université Libre de Bruxelles Centre Hospitalier Universitaire Brugmann Institut Jules Bordet Amgen (United States)Weston Park Cancer Centre

About

Jean-Jacques Body is an author at Université Libre de Bruxelles specializing in medicine, orthopaedics, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	542
2	Health Sciences	2	2	280
3	Cell Biology	1	1	10
4	Cellular Physiology	1	1	10
5	Medical Laboratory Science	1	1	241

Jean-Jacques Body

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study Alison Stopeck, Allan Lipton, Jean-Jacques Body, Journal of Clinical Oncology	2010	1.6K
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density Ian R. Reid, Jacques P. Brown, P. Burckhardt, New England Journal of Medicine	2002	871
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Jean-Jacques Body, Thierry Façon, Robert E. Coleman, Clinical Cancer Research	2006	488
Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Journal of Clinical Oncology	2007	382
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer Diana L. Ersfeld, D. Sudhaker Rao, Jean-Jacques Body, Clinical Biochemistry Therapeutic Drug MonitoringMedicineBioanalysisPharmacologyChemical Pathology	2004	241
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer Jean-Jacques Body, Ingo Diel, Richard H. Bell, Pain Cancer QualityPain TherapyPain MedicineOrthopaedic SurgeryOsteoporosis	2004	189
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer Alison Stopeck, Karim Fizazi, Jean-Jacques Body, Supportive Care in Cancer	2015	187
Hypocalcaemia in patients with metastatic bone disease treated with denosumab Jean-Jacques Body, Henry G. Bone, Richard H. De Boer, European Journal of Cancer	2015	144
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid Roger von Moos, Jean-Jacques Body, Blair Egerdie, Supportive Care in Cancer Bone DiseasePain TherapyZoledronic AcidHealth SciencesHealth-related Quality	2013	91
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases Roger von Moos, Jean-Jacques Body, Blair Egerdie, Supportive Care in Cancer	2015	77

Page 1